- Home
- ADXN vs SBFM Comparison
ADXN vs SBFM Comparison
Compare ADXN & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- SBFM
- Stock Information
- Founded
- ADXN 2002
- SBFM 2006
- Country
- ADXN Switzerland
- SBFM United States
- Employees
- ADXN N/A
- SBFM N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- SBFM Health Care
- Exchange
- ADXN Nasdaq
- SBFM Nasdaq
- Market Cap
- ADXN 10.1M
- SBFM 6.6M
- IPO Year
- ADXN N/A
- SBFM N/A
- Fundamental
- Price
- ADXN $9.48
- SBFM $1.47
- Analyst Decision
- ADXN Strong Buy
- SBFM Strong Buy
- Analyst Count
- ADXN 1
- SBFM 1
- Target Price
- ADXN $30.00
- SBFM $15.00
- AVG Volume (30 Days)
- ADXN 17.4K
- SBFM 183.9K
- Earning Date
- ADXN 08-11-2025
- SBFM 08-15-2025
- Dividend Yield
- ADXN N/A
- SBFM N/A
- EPS Growth
- ADXN N/A
- SBFM N/A
- EPS
- ADXN 0.10
- SBFM N/A
- Revenue
- ADXN $278,508.00
- SBFM $36,234,578.00
- Revenue This Year
- ADXN $86.57
- SBFM $192.48
- Revenue Next Year
- ADXN N/A
- SBFM N/A
- P/E Ratio
- ADXN $0.75
- SBFM N/A
- Revenue Growth
- ADXN N/A
- SBFM 35.51
- 52 Week Low
- ADXN $6.51
- SBFM $1.17
- 52 Week High
- ADXN $13.27
- SBFM $7.60
- Technical
- Relative Strength Index (RSI)
- ADXN 59.28
- SBFM 48.32
- Support Level
- ADXN $8.99
- SBFM $1.42
- Resistance Level
- ADXN $9.89
- SBFM $1.75
- Average True Range (ATR)
- ADXN 0.81
- SBFM 0.13
- MACD
- ADXN 0.06
- SBFM 0.00
- Stochastic Oscillator
- ADXN 78.07
- SBFM 22.22
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.